Physician

Anil K.v. Bhogaraju, MD

According to 2025 Medicare claims, Anil Bhogaraju, MD (NPI: 1578508222) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Denton, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75028-1713.

Bhogaraju's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 534 traditional Medicare patients, billed 145,767 HCPCS/CPT codes, and received $2,695,482 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,081 prescription claims across 156 beneficiaries totaling $3,343,132 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 38 claims. Open Payments data shows 75 records totaling $1,837. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,151,764 and ending at $2,695,482. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $604,606 to $3,343,132. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,359 to $1,360.